Predictive Value of Early MRI Measures for Long-Term Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis Receiving IFN β-1a SC tiw or IFN β-1a IM qw: Post Hoc Analyses of the EVIDENCE Study

被引：0
|
作者：
Coyle, Patricia [3 ]
Freedman, Mark [5 ,6 ]
Dangond, Fernando [1 ]
Fang, Juanzhi [2 ]
Reder, Anthony [4 ]
机构：
[1] EMD Serono Inc, Billerica, MA USA
[2] EMD Serono Inc, Rockland, MA USA
[3] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ Ottawa, Ottawa, ON, Canada
[6] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.189
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study
    Horakova, Dana
    Uher, Tomas
    Krasensky, Jan
    Seidl, Zdenek
    Ribbens, Annemie
    Van Hecke, Wim
    Billiet, Thibo
    Koendgen, Harold
    Freudensprung, Ulrich
    Hyde, Robert
    Vaneckova, Manuela
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [42] A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN β-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis
    Leuschen, MP
    Filipi, M
    Healey, K
    MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (06) : 636 - 642
  • [43] Long-Term Effects of Interferon Beta-1a Dose on Relapse Rate in Relapsing-Remitting Multiple Sclerosis: Results from a Post-Hoc Analysis of PRISMS Study Data
    Jeffery, Douglas
    Rivera, Victor M.
    NEUROLOGY, 2009, 72 (11) : A235 - A236
  • [44] Peginterferon beta-1a may improve recovery following relapses: post hoc analyses of the pivotal phase 3 ADVANCE study in patients with relapsing-remitting multiple sclerosis
    Kieseier, B. C.
    Scott, T. F.
    Newsome, S. D.
    Sheikh, S.
    Hung, S.
    You, X.
    Sperling, B.
    JOURNAL OF NEUROLOGY, 2014, 261 : S307 - S307
  • [45] Improved Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis on Long-Term Intramuscular Interferon Beta-1a: A 15-Year Study
    Weinstock-Guttman, Bianca
    Bermel, Robert
    Bourdette, Dennis
    Foulds, Pamela
    You, Phil
    Rudick, Richard
    NEUROLOGY, 2009, 72 (11) : A238 - A239
  • [46] Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing-remitting multiple sclerosis at year 1
    Traboulsee, Anthony
    Li, David K. B.
    Cascione, Mark
    Fang, Juanzhi
    Dangond, Fernando
    Miller, Aaron
    BMC NEUROLOGY, 2018, 18
  • [47] No evidence of disease activity status among patients with relapsing-remitting multiple sclerosis on long-term natalizumab treatment: data from a real-world cohort in the Czech Republic
    Horakova, D.
    Vaneckova, M.
    Krasensky, J.
    Seidl, Z.
    van Pesch, V.
    van Wijmeersch, B.
    Ribbens, A.
    van Hecke, W.
    Freudensprung, U.
    Hyde, R.
    Ho, P. -R.
    Kokic, M.
    Uher, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 409 - 410
  • [48] Effect of daclizumab HYP versus intramuscular interferon beta-1a on no evidence of disease activity in patients with relapsing-remitting multiple sclerosis: analysis of the DECIDE study
    Kappos, L.
    Havrdova, E.
    Giovannoni, G.
    Khatri, B. O.
    Gauthier, S. A.
    Greenberg, S.
    Wang, P.
    Elkins, J.
    Barbato, L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 22 - 22
  • [49] Relationship between early disease activity and long-term clinical outcome: results from the phase 3 TRANSFORMS study extension at 4.5 years in relapsing-remitting multiple sclerosis
    Hartung, H-P
    Barkhof, F.
    Comi, G.
    Kappos, L.
    Khatri, B.
    Montalban, X.
    Pelletier, J.
    Kornyeyeva, E.
    Meier, D. Piani
    Ritter, S.
    von Rosenstiel, P.
    Tomic, D.
    Cohen, J.
    JOURNAL OF NEUROLOGY, 2013, 260 : S71 - S71
  • [50] Early Predictors of Long-Term Response to Therapy in a 15-Year Follow-Up Study of Intramuscular Interferon Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis
    Bermel, Robert A.
    Weinstock-Guttman, Bianca
    Bourdette, Dennis
    Foulds, Pamela
    Hyde, Robert
    Pace, Amy
    Rudick, Richard
    NEUROLOGY, 2009, 72 (11) : A77 - A77
12345